Biomemory Opens DNA Shield Pilots for Molecular Data Storage

The Short Version

Biomemory has unveiled DNA Shield, a service designed to hold critical digital assets in synthetic DNA, according to TechRadar. Availability is limited to pilots running from October 15, 2026 through mid-2027. Biomemory told the publication it plans a full service after that period; this is not yet a broad rollout.

Why It Matters

The storage medium is a physical molecule rather than an online server. The report describes encoded information kept offline and without power for long-term storage. Biomemory presents cryptographic keys, intellectual property and regulated records as examples of material the service could hold. The practical question is whether that material can be recovered reliably when its owner needs it.

The Bigger Picture

The company’s product-management chief describes the move as asking customers to rely on the platform operationally, with a process running from encoding to authorized recovery. That is an ambition for the pilots to demonstrate, rather than independent proof of an end-to-end service. TechRadar reports subscriptions starting at €10,000 per month, placing the offer in an organizational context.

What to Watch

Capacity, retrieval time and independently measured recovery success are not specified in the available report. Its strong security language should not be treated as proof that the entire storage-and-recovery process is immune to attack. Pilot results would help show whether the molecular medium and the surrounding service work together as intended.

What proof would you want before trusting important records to synthetic DNA?